Boothbay Fund Management, LLC Nevro Corp Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$30.17 - $41.11 $221,176 - $301,377
7,331 New
7,331 $265,000
Q2 2022

Aug 15, 2022
BUY
$40.85 - $77.67 $422,674 - $803,651
10,347 New
10,347 $454,000
Q3 2020

Nov 16, 2020
SELL
$114.09 - $145.51 $73.6 Million - $93.9 Million
-645,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$89.45 - $129.85 $57.7 Million - $83.8 Million
645,000 New
645,000 $886,000

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email